- Home
- OTLK vs HYPR Comparison
OTLK vs HYPR Comparison
Compare OTLK & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | HYPR |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.8M | 104.0M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | OTLK | HYPR |
|---|---|---|
| Price | $2.18 | $1.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $4.00 | $1.28 |
| AVG Volume (30 Days) | ★ 3.4M | 594.5K |
| Earning Date | 12-24-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,505,322.00 | ★ $10,591,000.00 |
| Revenue This Year | N/A | $5.17 |
| Revenue Next Year | $342.80 | $35.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.79 | $0.53 |
| 52 Week High | $3.39 | $2.22 |
Technical Indicators
Market Signals| Indicator | OTLK | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 67.60 | 46.64 |
| Support Level | $1.91 | $0.97 |
| Resistance Level | $2.10 | $1.10 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 95.65 | 64.64 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.